In our study, the datasets obtained from TCGA-LIHC showed a unanimous underexpression of MEG3 in HCC as compared to in normal liver, pointing out that MEG3 acts as a bona fide tumor suppressor in HCC. This evidence concerns the gene MEG3 and hepatocellular carcinoma.